JUST IN　•　MarketWatch.com - Top Stories

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

SHARE THIS STORYPLUS UNLOCKS FAVORITES READ LATER AND SOURCE CONTROL

The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.

READ ORIGINAL REPORT ↗

THIS JUST HAPPENED PACKAGES THE WORLD INTO A FAST LIVE FEED SOURCE REPORTING STAYS ONE CLICK AWAY

RELATED POSTSMORE HEALTH

HEALTH　•　Ars Technica - All content

Most powerful obesity drug yet: People lost up to 25% of weight in trial

HEALTH　•　Latest Content - Men's Health

This Buzzy Supplement Has Horrifying Side Effects. Why Do Wellness Influencers Love It?

HEALTH　•　Ars Technica - All content

To keep drug prices high, pharma has been piling up the patents

HEALTH　•　Latest Content - Women's Health

Women’s Health Just Teamed Up With Equip to Research How Weight Bias Impacts PMOS Patients. The Data Is Concerning.

HEALTH　•　BBC News

'People forget we exist': Why older LGBTQ+ people fear losing identity

HEALTH　•　Latest Content - Women's Health

The 7 Best Under-Desk Treadmills, Tested and Reviewed by Fitness Editors

HEALTH　•　Glamour

I’m a Fashion Influencer With a Chronic Skin Condition—Here’s How It Shapes My Style

HEALTH　•　Variety

Billy Joel Gives Health Update After Brain Surgery: ‘I’m OK — It Sounds a Lot Worse Than It Actually Is’